(Q41537389)

2 October 2017

1 reference

title

Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. (English)

1 reference

2 October 2017

Masferrer JL

1

1 reference

PubMed ID

9229578

2 October 2017

Isakson PC

series ordinal

2

1 reference

PubMed ID

9229578

2 October 2017

Seibert K

series ordinal

3

1 reference

2 October 2017

1 June 1996

1 reference

Gastroenterology Clinics of North America

2 October 2017

1 reference

2 October 2017

25

1 reference

2 October 2017

363-372

1 reference

2 October 2017

2

1 reference

The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

The safety of Arthrotec in patients with rheumatoid arthritis or osteoarthritis: an assessment of the upper gastrointestinal tract by endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Regulation of prostaglandin synthase-1 and prostaglandin synthase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Effect of dexamethasone on in vivo prostanoid production in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Plasma concentrations, renal excretion, and tissue release of prostaglandins in the rat with dexamethasone-induced hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Actions and toxic effects of the nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970252-1

7 January 2021

10.1016/S0889-8553(05)70252-1

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9229578